Copyright Reports & Markets. All rights reserved.

Global Virtual Screening for Drug Discovery Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Virtual Screening for Drug Discovery by Type
    • 1.3.1 Overview: Global Virtual Screening for Drug Discovery Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Virtual Screening for Drug Discovery Consumption Value Market Share by Type in 2023
    • 1.3.3 Structure-based Virtual Screening (SBVS)
    • 1.3.4 Ligand-based Virtual Screening (LBVS)
    • 1.3.5 Hybrid Methods
  • 1.4 Global Virtual Screening for Drug Discovery Market by Application
    • 1.4.1 Overview: Global Virtual Screening for Drug Discovery Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Pharmaceutical Company
    • 1.4.3 Universities and Research Institutions
    • 1.4.4 Others
  • 1.5 Global Virtual Screening for Drug Discovery Market Size & Forecast
  • 1.6 Global Virtual Screening for Drug Discovery Market Size and Forecast by Region
    • 1.6.1 Global Virtual Screening for Drug Discovery Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Virtual Screening for Drug Discovery Market Size by Region, (2019-2030)
    • 1.6.3 North America Virtual Screening for Drug Discovery Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Virtual Screening for Drug Discovery Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Virtual Screening for Drug Discovery Market Size and Prospect (2019-2030)
    • 1.6.6 South America Virtual Screening for Drug Discovery Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East & Africa Virtual Screening for Drug Discovery Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 MedChemExpress
    • 2.1.1 MedChemExpress Details
    • 2.1.2 MedChemExpress Major Business
    • 2.1.3 MedChemExpress Virtual Screening for Drug Discovery Product and Solutions
    • 2.1.4 MedChemExpress Virtual Screening for Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 MedChemExpress Recent Developments and Future Plans
  • 2.2 TargetMol
    • 2.2.1 TargetMol Details
    • 2.2.2 TargetMol Major Business
    • 2.2.3 TargetMol Virtual Screening for Drug Discovery Product and Solutions
    • 2.2.4 TargetMol Virtual Screening for Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 TargetMol Recent Developments and Future Plans
  • 2.3 OpenEye Scientific
    • 2.3.1 OpenEye Scientific Details
    • 2.3.2 OpenEye Scientific Major Business
    • 2.3.3 OpenEye Scientific Virtual Screening for Drug Discovery Product and Solutions
    • 2.3.4 OpenEye Scientific Virtual Screening for Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 OpenEye Scientific Recent Developments and Future Plans
  • 2.4 Eurofins Discovery
    • 2.4.1 Eurofins Discovery Details
    • 2.4.2 Eurofins Discovery Major Business
    • 2.4.3 Eurofins Discovery Virtual Screening for Drug Discovery Product and Solutions
    • 2.4.4 Eurofins Discovery Virtual Screening for Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Eurofins Discovery Recent Developments and Future Plans
  • 2.5 Sygnature Discovery
    • 2.5.1 Sygnature Discovery Details
    • 2.5.2 Sygnature Discovery Major Business
    • 2.5.3 Sygnature Discovery Virtual Screening for Drug Discovery Product and Solutions
    • 2.5.4 Sygnature Discovery Virtual Screening for Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Sygnature Discovery Recent Developments and Future Plans
  • 2.6 Jubilant Biosys
    • 2.6.1 Jubilant Biosys Details
    • 2.6.2 Jubilant Biosys Major Business
    • 2.6.3 Jubilant Biosys Virtual Screening for Drug Discovery Product and Solutions
    • 2.6.4 Jubilant Biosys Virtual Screening for Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Jubilant Biosys Recent Developments and Future Plans
  • 2.7 Schrödinger, Inc.
    • 2.7.1 Schrödinger, Inc. Details
    • 2.7.2 Schrödinger, Inc. Major Business
    • 2.7.3 Schrödinger, Inc. Virtual Screening for Drug Discovery Product and Solutions
    • 2.7.4 Schrödinger, Inc. Virtual Screening for Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Schrödinger, Inc. Recent Developments and Future Plans
  • 2.8 Cresset Group
    • 2.8.1 Cresset Group Details
    • 2.8.2 Cresset Group Major Business
    • 2.8.3 Cresset Group Virtual Screening for Drug Discovery Product and Solutions
    • 2.8.4 Cresset Group Virtual Screening for Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Cresset Group Recent Developments and Future Plans
  • 2.9 ComputaBio
    • 2.9.1 ComputaBio Details
    • 2.9.2 ComputaBio Major Business
    • 2.9.3 ComputaBio Virtual Screening for Drug Discovery Product and Solutions
    • 2.9.4 ComputaBio Virtual Screening for Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 ComputaBio Recent Developments and Future Plans
  • 2.10 Profacgen
    • 2.10.1 Profacgen Details
    • 2.10.2 Profacgen Major Business
    • 2.10.3 Profacgen Virtual Screening for Drug Discovery Product and Solutions
    • 2.10.4 Profacgen Virtual Screening for Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Profacgen Recent Developments and Future Plans
  • 2.11 CD ComputaBio
    • 2.11.1 CD ComputaBio Details
    • 2.11.2 CD ComputaBio Major Business
    • 2.11.3 CD ComputaBio Virtual Screening for Drug Discovery Product and Solutions
    • 2.11.4 CD ComputaBio Virtual Screening for Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 CD ComputaBio Recent Developments and Future Plans
  • 2.12 Creative Biolabs
    • 2.12.1 Creative Biolabs Details
    • 2.12.2 Creative Biolabs Major Business
    • 2.12.3 Creative Biolabs Virtual Screening for Drug Discovery Product and Solutions
    • 2.12.4 Creative Biolabs Virtual Screening for Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Creative Biolabs Recent Developments and Future Plans
  • 2.13 BOC Sciences
    • 2.13.1 BOC Sciences Details
    • 2.13.2 BOC Sciences Major Business
    • 2.13.3 BOC Sciences Virtual Screening for Drug Discovery Product and Solutions
    • 2.13.4 BOC Sciences Virtual Screening for Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 BOC Sciences Recent Developments and Future Plans
  • 2.14 CKTTDB
    • 2.14.1 CKTTDB Details
    • 2.14.2 CKTTDB Major Business
    • 2.14.3 CKTTDB Virtual Screening for Drug Discovery Product and Solutions
    • 2.14.4 CKTTDB Virtual Screening for Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
    • 2.14.5 CKTTDB Recent Developments and Future Plans
  • 2.15 HitGen
    • 2.15.1 HitGen Details
    • 2.15.2 HitGen Major Business
    • 2.15.3 HitGen Virtual Screening for Drug Discovery Product and Solutions
    • 2.15.4 HitGen Virtual Screening for Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
    • 2.15.5 HitGen Recent Developments and Future Plans
  • 2.16 WuXi AppTec
    • 2.16.1 WuXi AppTec Details
    • 2.16.2 WuXi AppTec Major Business
    • 2.16.3 WuXi AppTec Virtual Screening for Drug Discovery Product and Solutions
    • 2.16.4 WuXi AppTec Virtual Screening for Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
    • 2.16.5 WuXi AppTec Recent Developments and Future Plans
  • 2.17 LeadBuilder
    • 2.17.1 LeadBuilder Details
    • 2.17.2 LeadBuilder Major Business
    • 2.17.3 LeadBuilder Virtual Screening for Drug Discovery Product and Solutions
    • 2.17.4 LeadBuilder Virtual Screening for Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
    • 2.17.5 LeadBuilder Recent Developments and Future Plans
  • 2.18 CSNpharm
    • 2.18.1 CSNpharm Details
    • 2.18.2 CSNpharm Major Business
    • 2.18.3 CSNpharm Virtual Screening for Drug Discovery Product and Solutions
    • 2.18.4 CSNpharm Virtual Screening for Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
    • 2.18.5 CSNpharm Recent Developments and Future Plans
  • 2.19 ChemNavigator
    • 2.19.1 ChemNavigator Details
    • 2.19.2 ChemNavigator Major Business
    • 2.19.3 ChemNavigator Virtual Screening for Drug Discovery Product and Solutions
    • 2.19.4 ChemNavigator Virtual Screening for Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
    • 2.19.5 ChemNavigator Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Virtual Screening for Drug Discovery Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Virtual Screening for Drug Discovery by Company Revenue
    • 3.2.2 Top 3 Virtual Screening for Drug Discovery Players Market Share in 2023
    • 3.2.3 Top 6 Virtual Screening for Drug Discovery Players Market Share in 2023
  • 3.3 Virtual Screening for Drug Discovery Market: Overall Company Footprint Analysis
    • 3.3.1 Virtual Screening for Drug Discovery Market: Region Footprint
    • 3.3.2 Virtual Screening for Drug Discovery Market: Company Product Type Footprint
    • 3.3.3 Virtual Screening for Drug Discovery Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Virtual Screening for Drug Discovery Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Virtual Screening for Drug Discovery Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Virtual Screening for Drug Discovery Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Virtual Screening for Drug Discovery Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Virtual Screening for Drug Discovery Consumption Value by Type (2019-2030)
  • 6.2 North America Virtual Screening for Drug Discovery Market Size by Application (2019-2030)
  • 6.3 North America Virtual Screening for Drug Discovery Market Size by Country
    • 6.3.1 North America Virtual Screening for Drug Discovery Consumption Value by Country (2019-2030)
    • 6.3.2 United States Virtual Screening for Drug Discovery Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Virtual Screening for Drug Discovery Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Virtual Screening for Drug Discovery Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Virtual Screening for Drug Discovery Consumption Value by Type (2019-2030)
  • 7.2 Europe Virtual Screening for Drug Discovery Consumption Value by Application (2019-2030)
  • 7.3 Europe Virtual Screening for Drug Discovery Market Size by Country
    • 7.3.1 Europe Virtual Screening for Drug Discovery Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Virtual Screening for Drug Discovery Market Size and Forecast (2019-2030)
    • 7.3.3 France Virtual Screening for Drug Discovery Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Virtual Screening for Drug Discovery Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Virtual Screening for Drug Discovery Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Virtual Screening for Drug Discovery Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Virtual Screening for Drug Discovery Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Virtual Screening for Drug Discovery Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Virtual Screening for Drug Discovery Market Size by Region
    • 8.3.1 Asia-Pacific Virtual Screening for Drug Discovery Consumption Value by Region (2019-2030)
    • 8.3.2 China Virtual Screening for Drug Discovery Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Virtual Screening for Drug Discovery Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Virtual Screening for Drug Discovery Market Size and Forecast (2019-2030)
    • 8.3.5 India Virtual Screening for Drug Discovery Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Virtual Screening for Drug Discovery Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Virtual Screening for Drug Discovery Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Virtual Screening for Drug Discovery Consumption Value by Type (2019-2030)
  • 9.2 South America Virtual Screening for Drug Discovery Consumption Value by Application (2019-2030)
  • 9.3 South America Virtual Screening for Drug Discovery Market Size by Country
    • 9.3.1 South America Virtual Screening for Drug Discovery Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Virtual Screening for Drug Discovery Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Virtual Screening for Drug Discovery Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Virtual Screening for Drug Discovery Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Virtual Screening for Drug Discovery Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Virtual Screening for Drug Discovery Market Size by Country
    • 10.3.1 Middle East & Africa Virtual Screening for Drug Discovery Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Virtual Screening for Drug Discovery Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Virtual Screening for Drug Discovery Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Virtual Screening for Drug Discovery Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Virtual Screening for Drug Discovery Market Drivers
  • 11.2 Virtual Screening for Drug Discovery Market Restraints
  • 11.3 Virtual Screening for Drug Discovery Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Virtual Screening for Drug Discovery Industry Chain
  • 12.2 Virtual Screening for Drug Discovery Upstream Analysis
  • 12.3 Virtual Screening for Drug Discovery Midstream Analysis
  • 12.4 Virtual Screening for Drug Discovery Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Virtual screening (VS) is a computational technique used in drug discovery to search libraries of small molecules in order to identify those structures which are most likely to bind to a drug target, typically a protein receptor or enzyme.
    According to our (Global Info Research) latest study, the global Virtual Screening for Drug Discovery market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.
    This report is a detailed and comprehensive analysis for global Virtual Screening for Drug Discovery market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
    Key Features:
    Global Virtual Screening for Drug Discovery market size and forecasts, in consumption value ($ Million), 2019-2030
    Global Virtual Screening for Drug Discovery market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
    Global Virtual Screening for Drug Discovery market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
    Global Virtual Screening for Drug Discovery market shares of main players, in revenue ($ Million), 2019-2024
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Virtual Screening for Drug Discovery
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Virtual Screening for Drug Discovery market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include MedChemExpress, TargetMol, OpenEye Scientific, Eurofins Discovery, Sygnature Discovery, Jubilant Biosys, Schrödinger, Inc., Cresset Group, ComputaBio, Profacgen, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Virtual Screening for Drug Discovery market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segmentation
    Virtual Screening for Drug Discovery market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Structure-based Virtual Screening (SBVS)
    Ligand-based Virtual Screening (LBVS)
    Hybrid Methods
    Market segment by Application
    Pharmaceutical Company
    Universities and Research Institutions
    Others
    Market segment by players, this report covers
    MedChemExpress
    TargetMol
    OpenEye Scientific
    Eurofins Discovery
    Sygnature Discovery
    Jubilant Biosys
    Schrödinger, Inc.
    Cresset Group
    ComputaBio
    Profacgen
    CD ComputaBio
    Creative Biolabs
    BOC Sciences
    CKTTDB
    HitGen
    WuXi AppTec
    LeadBuilder
    CSNpharm
    ChemNavigator
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Virtual Screening for Drug Discovery product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Virtual Screening for Drug Discovery, with revenue, gross margin, and global market share of Virtual Screening for Drug Discovery from 2019 to 2024.
    Chapter 3, the Virtual Screening for Drug Discovery competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Virtual Screening for Drug Discovery market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Virtual Screening for Drug Discovery.
    Chapter 13, to describe Virtual Screening for Drug Discovery research findings and conclusion.

    Buy now